This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
KITEA (E): IKEA's Opening Day
Casadesus-Masanell, Ramon; Yucaoglu, GamzeCase HBS-719422-EStrategyThe case opens in 2016 as Amine Benkirane, CEO of the furniture retailer KITEA, observes KITEA's dormant sales on the day IKEA opens its first store in Morocco. It then provides information on IKEA's Morocco store, as well as a detailed pricing comparison between IKEA products in Morocco and elsewhere and similar products sold by KITEA. The case then asks whether KITEA had any chance to compete with IKEA under the current circumstances, taking in...Starting at €5.74
-
Acibadem Healthcare Group
Herzlinger, Regina E.; Cekin, Esel; Kindred, Natalie; Yucaoglu, GamzeCase HBS-315120-EThis case focuses on Ac badem Healthcare Group's, Turkey's only premium nationwide hospital network, potential expansion strategies after it was acquired by International Healthcare Holdings Berhad (IHH) in 2011, the world's second-largest publicly listed health care group and a private hospital leader in Singapore and Malaysia. By providing perspectives on both Ac badem and IHH-Parkway-Pantai's operational models, growth aspirations, collabora...Starting at €8.20
-
General Electric, 1984 (Spanish Version)
Aguilar, Francis J.; Hamermesh, Richard G.; Brainard, Caroline E.Case HBS-302S36Knowledge and CommunicationDescribe los primeros cuatro años de permanencia de Jack Welch como CEO de las ofertas de General Electric Co. con las formas Welch ha tratado de actividades de estrategia y planificación del cambio de GE y sus intentos de hacer la empresa más empresarial.Starting at €8.20
-
Jumia's Path to Profitability
Casadesus-Masanell, Ramon; Armerding, Pippa Tubman; Yucaoglu, GamzeCase HBS-721355-EStrategyThe case opens in September 2019 as Sacha Poignonnec and Jeremy Hodara, co-founders and co-CEOs of Jumia, the leading Pan-African e-commerce platform, are contemplating the company's path to profitability in the aftermath of a fragile investor sentiment, as the company announced two internal issues in August 2019. The case chronicles the founding and expansion of Jumia and the iterations of its business model and describes its competitive outloo...Starting at €8.20
-
iyzico: recaudación de fondos en mercados emergentes (B)
Di Maggio, Marco; Yucaoglu, GamzeCase HBS-220S02FinanceEl caso se abre en julio de 2016 Barbaros Ozbugutu, co-fundador y CEO de la tecnología de pago iyzico puesta en marcha con sede en Estambul, contempla los pros y los contras de las diferentes hojas de término la compañía ha recibido para su ronda de Serie C. El caso, entonces informa al lector acerca de algunos cambios en las circunstancias que afectan a los términos de las ofertas preseleccionadas. Al final, el caso plantea esta pregunta: que se...Starting at €5.74
-
Bloodbuy
Hamermesh, Richard G.; Norris, MichaelCase HBS-815114-EEntrepreneurshipIn 2015, Chris Godfrey, founder and CEO of Bloodbuy has to consider the best path to growth for his young company that is attempting to disrupt the blood donation industry.Starting at €8.20
-
Amylin Pharmaceuticals B
Hamermesh, Richard G.; Knoop, Carin-IsabelCase HBS-813091-EEntrepreneurshipSupplement for case 809011Starting at €8.20
-
Novasys Medical
Hamermesh, Richard G.; Barley, LaurenCase HBS-810027-EEntrepreneurshipNovasys has developed a new medical device and procedure for the treatment of female stress urinary incontinence that is cheaper and can be performed in doctors' offices. In spite of FDA approval, the American Medical Association has been unwilling to approve the product for reimbursement. The case deals with the company's struggle to obtain a reimbursement code.Starting at €8.20
-
Impact Investing for Cancer
Hamermesh, Richard G.; Preble, MatthewCase HBS-818068-EStrategyStarting at €8.20
-
Medalogix
Hamermesh, Richard G.; Preble, MatthewCase HBS-815116-EEntrepreneurshipThis case examines an exciting new approach to health care that will help care providers identify when hospice services are the appropriate type of care for patients. The company, Medalogix, already has a product on the market that uses a proprietery algorithm to consider dozens of factors and determine when a patient qualifies for a hospice care eligability review. The product has started to gain traction, and the case explores how Medalogix can...Starting at €8.20